Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
Stopped barriers to accrual: delay until surgery and additional pre-operative visits
Conditions
Interventions
- DRUG: Hydroxychloroquine (HC)
Sponsor
University of Pittsburgh
Collaborators